DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION

SIDE- EFFECTS

CONTRAINDICATION

NURSING RESPONSIBILITIES

Generic Name: Piperacillin sodium and Tazobactam sodium

Pharmacologic class: Beta- lactamase inhibitor, extendedspectrum penicillin

Brand Name: Piptaz Dosage: 900 mg IV q 4 hours + 30cc D5W over 30 mins via soluset

Therapeutic class: Antibiotic

Chemical effect: Piperacillin inhibits cell wall synthesis during microorganism multiplication ; tazobactam increases piperacillin effectiveness by inactivating betalactamases, which destroys penicillin

Indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms

Anxiety, dizziness, fever, headache, abdominal pain, nausea vomiting, dyspnea

Contraindicated in patients with a history of allergic reactions to any of the betalactams, including penicillin and/or cephalosporin.

Obtain history of patients allergies. Advise patient to limit salt intake while taking drug because it contains 1.98 mEq of sodium per gram Monitor patients hydration Tell patient to report adverse reaction

Therapeutic effect: Kills susceptible bacteria

DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION

SIDE- EFFECTS

CONTRAINDICATION

NURSING RESPONSIBILITIES

Generic Name:
Ipratropium + Salbutamol

Therapeutic class: Anticholinergic/ Beta2 antagonist

Brand Name: Duavent Dosage: 2.5 mg q 4 hours via nebulizer

Therapeutic effect: Ipratropium bromidesalbutamol fixed-dose combination (FDC) maximizes the response to treatment in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) by increasing bronchodilation through 2 distinctly different mechanisms ie, anticholinergic (parasympatholytic) and 2agonist (sympathomimetic) effects. Simultaneous administration of both an anticholinergic (ipratropium bromide) and a 2sympathomimetic (salbutamol sulfate) produces a greater bronchodilator effect than when either drug is used alone..

Management of reversible bronchospasm associated with obstructive airway diseases (eg, bronchial asthma). For patients with chronic obstructive pulmonary disease (COPD) on a regular inhaled bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.

Headache, pain, influenza, chest pain, nausea. Bronchitis, dyspnea, coughing, pneumonia, bronchospasm, pharyngitis, sinusitis, rhinitis. Edema, fatigue, Hypertension, dizziness, nervousness, paresthesia, tremor, dysphonia, insomnia, diarrhea, dry mouth, dyspepsia, vomiting, arrhythmia, palpitation, tachycardia, arthralgia, angina, increased sputum, taste perversion and UTI/dysuria. Allergictype reactions.

Hypersensitivity to soya lecithin or related food products eg, soybeans or peanuts; and to any component of Duavent or to atropine and its derivatives. Hypertrophic obstructive cardiomyopathy or tachyarrhythmia.

Caution patient to avoid hazardous activities until stabilized on drug. Instruct patient on the proper way of drug inhalation and not to exceed dose under any circumstances. Instruct to rinse mouth after inhalation Teach patient how to use and clean nebulizer. Inform patient that drug may have foul smell or taste.

DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION

SIDE- EFFECTS

CONTRAINDICATION

NURSING RESPONSIBILITIES

Generic Name: Phenylephrine HCl Chlorphenamine Maleate

Pharmacologic class: Therapeutic class: Antihistamine Decongestant

Chlorphenamine Maleate Competitively antagonizes histamine at H 1receptor sites.

Phenylephrine HCl Stimulates postsynaptic alpha-receptors, resulting in vasoconstriction, which reduces congestion.

Temporary relief of symptoms of allergic rhinitis, vasomotor rhinitis, sinusitis, and the common cold

Brand Name: Disudrin Dosage: 5 ml 3x a day

Nervousness, restlessness, insomnia, headache, increase in blood pressure, and feelings of tightness in the chest. Excessive doses may produce irregular heartbeat, dilation of pupils and excitation.

Hypersensitivity or idiosyncratic reaction to any ingredients of product; severe hypertension; severe coronary artery disease; narrow-angle glaucoma; urinary retention; hyperthyroidism; peptic ulcer; asthma attack; MAO inhibitor therapy or for 2 wk after stopping MAO inhibitor therapy.

Advise caregiver to use dosing spoon or syringe when giving syrup to children. Advise patient to take with food or milk if GI upset occurs. Advise patient to take last dose late in the afternoon or early evening to reduce chance of drug causing sleeplessness. Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication but to inform health care provider. Caution patient not to take any OTC antihistamines or decongestants while taking this medication.